Vaccinex, Inc.
VCNX · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,057 | $6,892 | $11,850 | $9,211 |
| - Cash | $1,107 | $2,906 | $233 | $2,972 |
| + Debt | $25 | $59 | $122 | $185 |
| Enterprise Value | $975 | $4,045 | $11,739 | $6,424 |
| Revenue | $213 | $52 | $232 | $104 |
| % Growth | 309.6% | -77.6% | 123.1% | – |
| Gross Profit | $213 | $52 | $232 | $77 |
| % Margin | 100% | 100% | 100% | 74% |
| EBITDA | -$3,355 | -$5,708 | -$5,606 | -$3,842 |
| % Margin | -1,575.1% | -10,976.9% | -2,416.4% | -3,694.2% |
| Net Income | -$3,374 | -$5,732 | -$5,631 | -$3,897 |
| % Margin | -1,584% | -11,023.1% | -2,427.2% | -3,747.1% |
| EPS Diluted | -1.61 | -2.83 | -3.1 | -2.94 |
| % Growth | 43.1% | 8.7% | -5.4% | – |
| Operating Cash Flow | -$3,932 | -$3,207 | -$4,415 | -$4,632 |
| Capital Expenditures | $0 | -$8 | -$14 | $0 |
| Free Cash Flow | -$3,932 | -$3,215 | -$4,429 | -$4,632 |